1228 related articles for article (PubMed ID: 8877711)
21. Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma.
Mocellin S; Del Fiore P; Guarnieri L; Scalerta R; Foletto M; Chiarion V; Pilati P; Nitti D; Lise M; Rossi CR
Int J Cancer; 2004 Sep; 111(5):741-5. PubMed ID: 15252844
[TBL] [Abstract][Full Text] [Related]
22. Detection and characterization of residual disease in breast cancer.
Pantel K; Felber E; Schlimok G
J Hematother; 1994; 3(4):315-22. PubMed ID: 7735827
[TBL] [Abstract][Full Text] [Related]
23. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.
Conzelmann M; Dieterle CP; Linnemann U; Berger MR
Int J Cancer; 2003 Nov; 107(4):617-28. PubMed ID: 14520701
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of micrometastatic cancer cells.
Pantel K; Hosch SB
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):18S-21S. PubMed ID: 11599890
[TBL] [Abstract][Full Text] [Related]
26. [Minimal residual disease in breast carcinoma].
Janků F; Novotný J; Vedralová J; Kleibl Z; Matous B; Petruzelka L
Cas Lek Cesk; 2002 Aug; 141(17):546-50. PubMed ID: 12404958
[TBL] [Abstract][Full Text] [Related]
27. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.
van Dongen GA; Brakenhoff RM; ten Brink CT; van Gog FB; de Bree R; Quak JJ; Snow GB
Anticancer Res; 1996; 16(4C):2409-13. PubMed ID: 8816843
[TBL] [Abstract][Full Text] [Related]
29. [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
Rosenberg R; Nekarda H; Thorban S; Siewert JR
Acta Med Austriaca Suppl; 2002; 59():42-53. PubMed ID: 12506760
[TBL] [Abstract][Full Text] [Related]
30. CK20 gene expression: technical limits for the detection of circulating tumor cells.
Champelovier P; Mongelard F; Seigneurin D
Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150
[TBL] [Abstract][Full Text] [Related]
31. Disseminated tumor cells: diagnosis, prognostic relevance, and phenotyping.
Pantel K; Otte M
Recent Results Cancer Res; 2001; 158():14-24. PubMed ID: 11092029
[TBL] [Abstract][Full Text] [Related]
32. Tumor-associated antigens recognized by human monoclonal antibodies.
Chang HR; Koda K; McKnight ME; Glassy MC
Ann Surg Oncol; 1994 May; 1(3):213-21. PubMed ID: 7842291
[TBL] [Abstract][Full Text] [Related]
33. Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE.
Cheung IY; Cheung NK
Med Pediatr Oncol; 2001 Jan; 36(1):210-2. PubMed ID: 11464887
[TBL] [Abstract][Full Text] [Related]
34. Utilization of polymerase chain reaction technology in the detection of solid tumors.
Raj GV; Moreno JG; Gomella LG
Cancer; 1998 Apr; 82(8):1419-42. PubMed ID: 9554517
[TBL] [Abstract][Full Text] [Related]
35. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM
J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924
[TBL] [Abstract][Full Text] [Related]
36. DTCs in breast cancer: clinical research and practice.
Janni W; Rack B; Kasprowicz N; Scholz C; Hepp P
Recent Results Cancer Res; 2012; 195():173-8. PubMed ID: 22527504
[TBL] [Abstract][Full Text] [Related]
37. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease.
Soeth E; Röder C; Juhl H; Krüger U; Kremer B; Kalthoff H
Int J Cancer; 1996 Aug; 69(4):278-82. PubMed ID: 8797868
[TBL] [Abstract][Full Text] [Related]
38. [Monoclonal antibodies--new probes for diagnosis and therapy. Their use as an example of the micrometastasizing of solid tumors].
Schlimok G; Funke I; Bock B; Schweiberer B; Riethmüller G
Arzneimittelforschung; 1988 Mar; 38(3A):435-7. PubMed ID: 3293575
[TBL] [Abstract][Full Text] [Related]
39. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
[TBL] [Abstract][Full Text] [Related]
40. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.
Pantel K; Schlimok G; Angstwurm M; Weckermann D; Schmaus W; Gath H; Passlick B; Izbicki JR; Riethmüller G
J Hematother; 1994; 3(3):165-73. PubMed ID: 7530132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
